These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 15203574)
21. Maternal serum screening of Palestinian women in the West Bank. Husseini A; Akkawi M East Mediterr Health J; 2005 Jul; 11(4):824-7. PubMed ID: 16700399 [TBL] [Abstract][Full Text] [Related]
22. Predicting the result of additional second-trimester markers from a woman's first-trimester marker profile: a new concept in Down syndrome screening. Maymon R; Cuckle H; Jones R; Reish O; Sharony R; Herman A Prenat Diagn; 2005 Dec; 25(12):1102-6. PubMed ID: 16231324 [TBL] [Abstract][Full Text] [Related]
23. Maternal biochemical serum screening for Down syndrome in pregnancy with human immunodeficiency virus infection. Le Meaux JP; Tsatsaris V; Schmitz T; Fulla Y; Launay O; Goffinet F; Azria E Obstet Gynecol; 2008 Aug; 112(2 Pt 1):223-30. PubMed ID: 18669715 [TBL] [Abstract][Full Text] [Related]
24. [Tri-test: clinical considerations on 1784 cases]. Caserta D; Baldi M; Carta G; Moscarini M Minerva Ginecol; 1998 Mar; 50(3):73-5. PubMed ID: 9595918 [TBL] [Abstract][Full Text] [Related]
25. [Comment on the contribution by Benz et al.: Serum screening for Down syndrome in women under 35 years of age with an age independent index]. Reynolds T; Pistorius K; Spencer K; John R Z Geburtshilfe Neonatol; 1995; 199(3):128-9. PubMed ID: 7553259 [No Abstract] [Full Text] [Related]
26. [Comparison between age-dependent (Wald alpha program) and age-independent (Ulm index) analysis program for prenatal detection of Down's syndrome with serum markers]. Zwahr C; Voss P; Kistner G Z Geburtshilfe Neonatol; 1996; 200(5):181-5. PubMed ID: 9035827 [TBL] [Abstract][Full Text] [Related]
27. [Antenatal screening for Down syndrome: a smattering of epidemiology]. Boulvain M; Billieux MH; Irion O Rev Med Suisse; 2008 Oct; 4(176):2276-8, 2280. PubMed ID: 19025178 [TBL] [Abstract][Full Text] [Related]
28. First and second-trimester biochemical markers of chromosomal anomalies and their relationship to maternal haemoglobin levels. Cowans NJ; Spencer K Prenat Diagn; 2005 Aug; 25(8):693-9. PubMed ID: 16050001 [TBL] [Abstract][Full Text] [Related]
29. Pregnancy outcomes of women with positive serum screening results for Down syndrome and trisomy 18. Summers AM; Huang T; Wyatt PR Prenat Diagn; 2002 Mar; 22(3):269-71. PubMed ID: 11920909 [No Abstract] [Full Text] [Related]
30. Multicenter study of first-trimester screening for trisomy 21 in 75 821 pregnancies: results and estimation of the potential impact of individual risk-orientated two-stage first-trimester screening. Nicolaides KH; Spencer K; Avgidou K; Faiola S; Falcon O Ultrasound Obstet Gynecol; 2005 Mar; 25(3):221-6. PubMed ID: 15736186 [TBL] [Abstract][Full Text] [Related]
31. Evaluation of second trimester maternal serum screening for Down's Syndrome using the Spiegelhalter-Knill-Jones (S-KJ) approach. Hwa HL; Yen MF; Hsieh FJ; Ko TM; Chen TH J Perinat Med; 2004; 32(5):407-12. PubMed ID: 15493716 [TBL] [Abstract][Full Text] [Related]
32. Human chorionic gonadotropin and plasma protein-A in alpha0-thalassemia pregnancies. Ong CY; Lee CP; Leung KY; Lau E; Tang MH Obstet Gynecol; 2006 Sep; 108(3 Pt 1):651-5. PubMed ID: 16946227 [TBL] [Abstract][Full Text] [Related]
33. Repeat testing in antenatal screening for Down syndrome using dimeric inhibin-A in combination with other maternal serum markers. Hackshaw AK; Wald NJ Prenat Diagn; 2001 Jan; 21(1):58-61. PubMed ID: 11180243 [TBL] [Abstract][Full Text] [Related]
34. Using record linkage and manual follow-up to evaluate the Victorian maternal serum screening quadruple test for Down's syndrome, trisomy 18 and neural tube defects. Jaques AM; Collins VR; Haynes K; Sheffield LJ; Francis I; Forbes R; Halliday JL J Med Screen; 2006; 13(1):8-13. PubMed ID: 16569299 [TBL] [Abstract][Full Text] [Related]
35. Major fetal abnormalities associated with positive screening tests for Smith-Lemli-Opitz syndrome (SLOS). Craig WY; Haddow JE; Palomaki GE; Roberson M Prenat Diagn; 2007 May; 27(5):409-14. PubMed ID: 17286308 [TBL] [Abstract][Full Text] [Related]
36. Midtrimester triple-test levels in women with chronic hypertension and altered renal function. Shenhav S; Gemer O; Sherman DJ; Peled R; Segal S Prenat Diagn; 2003 Feb; 23(2):166-7. PubMed ID: 12575027 [TBL] [Abstract][Full Text] [Related]
37. Reliability of second trimester triple screening for Down syndrome in rhesus-negative women. Muhcu M; Mungen E; Dundar O; Bodur S; Tutuncu L; Atay V; Ozcan O; Yergok YZ J Perinatol; 2007 May; 27(5):268-71. PubMed ID: 17363912 [TBL] [Abstract][Full Text] [Related]
38. A demographic approach to the assessment of Down syndrome screening performance. van der Veen WJ; Beekhuis JR; Cornel MC; Mantingh A; de Walle HE; de Wolf BT Prenat Diagn; 1997 Aug; 17(8):717-24. PubMed ID: 9267894 [TBL] [Abstract][Full Text] [Related]